|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of May 31, 2021
|
Q1 FY2021
As of Feb 28, 2021
|
Q4 FY2020
As of Nov 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Accounts receivable-other | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Security deposit | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Project advances | ||||||||||||||||||||
| Project advances- related party | ||||||||||||||||||||
| Project advances-related party | ||||||||||||||||||||
| Loan payable | ||||||||||||||||||||
| Convertible promissory notes | ||||||||||||||||||||
| Embedded derivative liability | ||||||||||||||||||||
| Notes payable-related parties | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Commitments and Contingencies | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS' (DEFICIT) EQUITY | ||||||||||||||||||||
| Preferred stock Series A, $0.001 par value 300,000,000, shares authorized, 226,206,479 and 226,206,479, shares issued and outstanding as of December 31, 2025, and December 31, 2024, respectively | ||||||||||||||||||||
| Total preferred stock Series A, $0.001 par value 300,000,000, shares authorized, 226,206,479 and 226,206,479, shares issued and outstanding as of December 31, 2025, and December 31, 2024, respectively | ||||||||||||||||||||
| Common stock, Par Value $0.001, 4,500,000,000 shares authorized, 110,994,283 and 109,369,075 issued and outstanding as of December 31, 2025, and December 31, 2024 | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated Deficit | ||||||||||||||||||||
| Total Stockholders' (Deficit) Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' (Deficit) Equity | ||||||||||||||||||||
Loading...
